Authors
Paul A Kroon, Michael N Clifford, Alan Crozier, Andrea J Day, Jennifer L Donovan, Claudine Manach, Gary Williamson
Publication date
2004/7/1
Source
The American journal of clinical nutrition
Volume
80
Issue
1
Pages
15-21
Publisher
Elsevier
Description
Human intervention studies have provided clear evidence that dietary polyphenols (eg, flavonoids—eg, flavonols—and isoflavones) are at least partly absorbed and that they have the potential to exert biological effects. Biological activity of polyphenols is often assessed by using cultured cells as tissue models; in almost all such studies, cells are treated with aglycones or polyphenol-rich extracts (derived from plants and foods), and data are reported at concentrations that elicited a response. There are 2 inherent flaws in such an approach. First, plasma and tissues are not exposed in vivo to polyphenols in these forms. Several human studies have identified the nature of polyphenol conjugates in vivo and have shown that dietary polyphenols undergo extensive modification during first-pass metabolism so that the forms reaching the blood and tissues are, in general, neither aglycones (except for green tea catechins …
Total citations
2004200520062007200820092010201120122013201420152016201720182019202020212022202320242193143494948294937525050333122171517105
Scholar articles
PA Kroon, MN Clifford, A Crozier, AJ Day, JL Donovan… - The American journal of clinical nutrition, 2004